|
| Exchange Received Time 29/11/2018 12:51:59 Exchange Disseminated Time 29/11/2018 12:52:08 Time Taken 00:00:09 | Re.: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to the provisions of Regulation 30 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that subject to applicable laws, Drug Discovery and Development Solutions Limited, Singapore ('DDDSL'), a wholly-owned subsidiary company, has entered into Stock Purchase Agreement on November 29, 2018 for acquiring 534,194 shares of Common Stock of Inipharm Inc., USA.
Relevant details are given in Annexure-A to this letter.
We request you to take the same on record.
|
|
|